A new approach for treating AD: Guifu Dihuang Pills improves brain insulin resistance by promoting NrCAM to activate the EGFR/PI3K/Akt signaling pathway
作者
C. C. Yu,Liu Liu,Zhijian Lu,Minxia Chen,Na Yang,Zongyuan Li,Lanxin Bai,Changyu Li,Xiaojie Zhou